|
EspAddText
EspRemoveText
|
Bill C-2 An Act to amend the Controlled Drugs and Substances Act (Respect for Communities Act)
|
Parliamentary submission
|
2015
|
|
EspAddText
EspRemoveText
|
Complementary and alternative medicine (update 2015)
|
Policy document
|
2015
|
|
EspAddText
EspRemoveText
|
Harms associated with opioids and other psychoactive prescription drugs
|
Policy document
|
2015
|
|
EspAddText
EspRemoveText
|
CMA's Response to Health Canada's Public Consultation Guide to New Authorities in reference to Bill C-17, Protecting Canadians from Unsafe Drugs Act
(Vanessa's Law)
|
Response to consultation
|
2015
|
|
EspAddText
EspRemoveText
|
Proposed approach to the regulation of cannabis
|
Response to consultation
|
2018
|
|
EspAddText
EspRemoveText
|
CMA’s Recommendations for Bill S-5 An Act to amend the Tobacco Act and the Non-smokers’ Health Act and to make consequential amendments to other Acts
|
Parliamentary submission
|
2018
|
|
EspAddText
EspRemoveText
|
Health and health care for an aging population
|
Policy document
|
2018
|
|
EspAddText
EspRemoveText
|
Bill C-45: The Cannabis Act
|
Parliamentary submission
|
2018
|
|
EspAddText
EspRemoveText
|
Consultation on proposed front-of-package labelling
|
Response to consultation
|
2018
|
|
EspAddText
EspRemoveText
|
Health Canada consultation on restriction of marketing and advertising of opioids
|
Response to consultation
|
2018
|
|
EspAddText
EspRemoveText
|
Health Canada consultation on regulatory amendments regarding tramadol
|
Response to consultation
|
2018
|
|
EspAddText
EspRemoveText
|
Support life-saving supervised consumption and overdose prevention sites: open letter to Premier Doug Ford and Health Minister Christine Elliott
|
Policy endorsement
|
2018
|
|
EspAddText
EspRemoveText
|
Health Canada consultation on tobacco products regulations (plain and standardized appearance)
|
Response to consultation
|
2018
|
|
EspAddText
EspRemoveText
|
Implementation of National Pharmacare
|
Response to consultation
|
2018
|
|
EspAddText
EspRemoveText
|
Health Canada consultation on Canadian drugs and substances strategy
|
Response to consultation
|
2018
|
|
EspAddText
EspRemoveText
|
Health Canada’s consultation on new health-related labelling for tobacco products
|
Response to consultation
|
2018
|